Micro-PET/CT Monitoring of Herpes Thymidine Kinase Suicide Gene Therapy in a Prostate Cancer Xenograft: The Advantage of a Cell-specific Transcriptional Targeting Approach

Cancer gene therapy based on tissue-restricted expression of cytotoxic gene should achieve superior therapeutic index over an unrestricted method. This study compared the therapeutic effects of a highly augmented, prostate-specific gene expression method to a strong constitutive promoter-driven appr...

Full description

Saved in:
Bibliographic Details
Main Authors: Mai Johnson, Makoto Sato, Jeremy Burton, Sanjiv S. Gambhir, Michael Carey, Lily Wu
Format: Article
Language:English
Published: SAGE Publishing 2005-10-01
Series:Molecular Imaging
Online Access:https://doi.org/10.2310/7290.2005.05154
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841564492795740160
author Mai Johnson
Makoto Sato
Jeremy Burton
Sanjiv S. Gambhir
Michael Carey
Lily Wu
author_facet Mai Johnson
Makoto Sato
Jeremy Burton
Sanjiv S. Gambhir
Michael Carey
Lily Wu
author_sort Mai Johnson
collection DOAJ
description Cancer gene therapy based on tissue-restricted expression of cytotoxic gene should achieve superior therapeutic index over an unrestricted method. This study compared the therapeutic effects of a highly augmented, prostate-specific gene expression method to a strong constitutive promoter-driven approach. Molecular imaging was coupled to gene therapy to ascertain real-time therapeutic activity. The imaging reporter gene (luciferase) and the cytotoxic gene (herpes simplex thymidine kinase) were delivered by adenoviral vectors injected directly into human prostate tumors grafted in SCID mice. Serial bioluminescence imaging, positron emission tomography, and computed tomography revealed restriction of gene expression to the tumors when prostate-specific vector was employed. In contrast, administration of constitutive active vector resulted in strong signals in the liver. Liver serology, tissue histology, and frail condition of animals confirmed liver toxicity suffered by the constitutive active cohorts, whereas the prostate-targeted group was unaffected. The extent of tumor killing was analyzed by apoptotic staining and human prostate marker (prostate-specific antigen). Overall, the augmented prostate-specific expression system was superior to the constitutive approach in safeguarding against systemic toxicity, while achieving effective tumor killing. Integrating noninvasive imaging into cytotoxic gene therapy will provide a useful strategy to monitor gene expression and therapeutic efficacy in future clinical protocols.
format Article
id doaj-art-c9be0301d0834bde9b888f55a0dfb2e2
institution Kabale University
issn 1536-0121
language English
publishDate 2005-10-01
publisher SAGE Publishing
record_format Article
series Molecular Imaging
spelling doaj-art-c9be0301d0834bde9b888f55a0dfb2e22025-01-02T22:41:16ZengSAGE PublishingMolecular Imaging1536-01212005-10-01410.2310/7290.2005.0515410.2310_7290.2005.05154Micro-PET/CT Monitoring of Herpes Thymidine Kinase Suicide Gene Therapy in a Prostate Cancer Xenograft: The Advantage of a Cell-specific Transcriptional Targeting ApproachMai Johnson0Makoto Sato1Jeremy Burton2Sanjiv S. Gambhir3Michael Carey4Lily Wu5University of California Los AngelesUniversity of California Los AngelesUniversity of California Los AngelesStanford University, USAUniversity of California Los AngelesUniversity of California Los AngelesCancer gene therapy based on tissue-restricted expression of cytotoxic gene should achieve superior therapeutic index over an unrestricted method. This study compared the therapeutic effects of a highly augmented, prostate-specific gene expression method to a strong constitutive promoter-driven approach. Molecular imaging was coupled to gene therapy to ascertain real-time therapeutic activity. The imaging reporter gene (luciferase) and the cytotoxic gene (herpes simplex thymidine kinase) were delivered by adenoviral vectors injected directly into human prostate tumors grafted in SCID mice. Serial bioluminescence imaging, positron emission tomography, and computed tomography revealed restriction of gene expression to the tumors when prostate-specific vector was employed. In contrast, administration of constitutive active vector resulted in strong signals in the liver. Liver serology, tissue histology, and frail condition of animals confirmed liver toxicity suffered by the constitutive active cohorts, whereas the prostate-targeted group was unaffected. The extent of tumor killing was analyzed by apoptotic staining and human prostate marker (prostate-specific antigen). Overall, the augmented prostate-specific expression system was superior to the constitutive approach in safeguarding against systemic toxicity, while achieving effective tumor killing. Integrating noninvasive imaging into cytotoxic gene therapy will provide a useful strategy to monitor gene expression and therapeutic efficacy in future clinical protocols.https://doi.org/10.2310/7290.2005.05154
spellingShingle Mai Johnson
Makoto Sato
Jeremy Burton
Sanjiv S. Gambhir
Michael Carey
Lily Wu
Micro-PET/CT Monitoring of Herpes Thymidine Kinase Suicide Gene Therapy in a Prostate Cancer Xenograft: The Advantage of a Cell-specific Transcriptional Targeting Approach
Molecular Imaging
title Micro-PET/CT Monitoring of Herpes Thymidine Kinase Suicide Gene Therapy in a Prostate Cancer Xenograft: The Advantage of a Cell-specific Transcriptional Targeting Approach
title_full Micro-PET/CT Monitoring of Herpes Thymidine Kinase Suicide Gene Therapy in a Prostate Cancer Xenograft: The Advantage of a Cell-specific Transcriptional Targeting Approach
title_fullStr Micro-PET/CT Monitoring of Herpes Thymidine Kinase Suicide Gene Therapy in a Prostate Cancer Xenograft: The Advantage of a Cell-specific Transcriptional Targeting Approach
title_full_unstemmed Micro-PET/CT Monitoring of Herpes Thymidine Kinase Suicide Gene Therapy in a Prostate Cancer Xenograft: The Advantage of a Cell-specific Transcriptional Targeting Approach
title_short Micro-PET/CT Monitoring of Herpes Thymidine Kinase Suicide Gene Therapy in a Prostate Cancer Xenograft: The Advantage of a Cell-specific Transcriptional Targeting Approach
title_sort micro pet ct monitoring of herpes thymidine kinase suicide gene therapy in a prostate cancer xenograft the advantage of a cell specific transcriptional targeting approach
url https://doi.org/10.2310/7290.2005.05154
work_keys_str_mv AT maijohnson micropetctmonitoringofherpesthymidinekinasesuicidegenetherapyinaprostatecancerxenografttheadvantageofacellspecifictranscriptionaltargetingapproach
AT makotosato micropetctmonitoringofherpesthymidinekinasesuicidegenetherapyinaprostatecancerxenografttheadvantageofacellspecifictranscriptionaltargetingapproach
AT jeremyburton micropetctmonitoringofherpesthymidinekinasesuicidegenetherapyinaprostatecancerxenografttheadvantageofacellspecifictranscriptionaltargetingapproach
AT sanjivsgambhir micropetctmonitoringofherpesthymidinekinasesuicidegenetherapyinaprostatecancerxenografttheadvantageofacellspecifictranscriptionaltargetingapproach
AT michaelcarey micropetctmonitoringofherpesthymidinekinasesuicidegenetherapyinaprostatecancerxenografttheadvantageofacellspecifictranscriptionaltargetingapproach
AT lilywu micropetctmonitoringofherpesthymidinekinasesuicidegenetherapyinaprostatecancerxenografttheadvantageofacellspecifictranscriptionaltargetingapproach